Folgen
Alessio Aghemo
Alessio Aghemo
Humanitas University
Bestätigte E-Mail-Adresse bei hunimed.eu
Titel
Zitiert von
Zitiert von
Jahr
EASL Clinical Practice Guidelines: management of hepatitis C virus infection
European Association For The Study Of The Liver
Journal of hepatology 55 (2), 245-264, 2011
22532011
EASL recommendations on treatment of hepatitis C 2018
European Association for The Study of The Liver
Journal of hepatology 69 (2), 461-511, 2018
1736*2018
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
15012020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
4472021
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
R D'Ambrosio, A Aghemo, MG Rumi, G Ronchi, MF Donato, V Paradis, ...
Hepatology 56 (2), 532-543, 2012
4452012
EASL recommendations on treatment of hepatitis C: final update of the series☆
JM Pawlotsky, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, ...
Journal of hepatology 73 (5), 1170-1218, 2020
4082020
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ...
The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019
3702019
COVID-19 and liver disease
J Sun, A Aghemo, A Forner, L Valenti
Liver international 40 (6), 1278-1281, 2020
3452020
High rates of 30-day mortality in patients with cirrhosis and COVID-19
M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ...
Journal of hepatology 73 (5), 1063-1071, 2020
3012020
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
2882011
Randomized study of peginterferon-α2a plus ribavirin vs peginterferon-α2b plus ribavirin in chronic hepatitis C
MG Rumi, A Aghemo, GM Prati, R D'Ambrosio, MF Donato, R Soffredini, ...
Gastroenterology 138 (1), 108-115, 2010
2852010
EASL recommendations on treatment of hepatitis C 2014
European Association for The Study of The Liver
Journal of Hepatology 61 (2), 373-395, 2014
2362014
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ...
Scientific reports 7 (1), 4492, 2017
1942017
Recommendations for the management of hepatitis C virus infection among people who inject drugs
J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ...
International Journal of Drug Policy 26 (10), 1028-1038, 2015
1942015
Treatment with ledipasvir–sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial
M Colombo, A Aghemo, H Liu, J Zhang, H Dvory-Sobol, R Hyland, C Yun, ...
Annals of internal medicine 166 (2), 109-117, 2017
1892017
Impact of COVID-19 on global HCV elimination efforts
S Blach, LA Kondili, A Aghemo, Z Cai, E Dugan, C Estes, I Gamkrelidze, ...
Journal of hepatology 74 (1), 31-36, 2021
1842021
Genetic variation in the interleukin28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
F Marabita, A Aghemo, S De Nicola, MG Rumi, C Cheroni, R Scavelli, ...
Hepatology 54 (4), 1127-1134, 2011
1782011
Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy
M Cecconi, D Piovani, E Brunetta, A Aghemo, M Greco, M Ciccarelli, ...
Journal of clinical medicine 9 (5), 1548, 2020
1692020
The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response
R D’Ambrosio, A Aghemo, M Fraquelli, MG Rumi, MF Donato, V Paradis, ...
Journal of hepatology 59 (2), 251-256, 2013
1692013
New horizons in hepatitis C antiviral therapy with direct‐acting antivirals
A Aghemo, R De Francesco
Hepatology 58 (1), 428-438, 2013
1592013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20